📅 PUBMED DAILY TRIAGE — 2026-06-17
Window: 2026-06-16T09:00:00Z → 2026-06-17T09:00:00Z (CRDT) Topics scanned: 9 | Articles reviewed: ~185 candidates | Records kept: 23 full + 4 count-only High priority: 8 | Standard: 15 | Low/archive: 4 | Unsolicited finds: 2 Run status: ✅ SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
Hematologic Malignancies (AML, MDS, CLL, MPN, Lymphoma)
- TR-2026-06-17-001 / PMID 42303978 · Detection of MEN1 resistance mutations in cfDNA from acute leukemia patients treated with menin inhibitors · 9/10 · MSK team (Stein, Levine, Cai) demonstrates real-time cfDNA surveillance of menin inhibitor resistance — critical for a drug class just entering broad clinical use. 🟠 NOVEL_TREATMENT
- TR-2026-06-17-004 / PMID 42302353 · Outcomes of CAR T-Cell Therapy in transformed indolent NHL vs de novo DLBCL (Italian CAR T-SIE, n=438) · 8/10 · Counter-intuitive finding: TiNHL patients achieve superior response and survival vs dnDLBCL (ORR 83% vs 69%, 2-yr OS 61% vs 48%, p<0.01) — directly impacts CAR-T patient selection strategy. 🟠 NOVEL_TREATMENT
- TR-2026-06-17-003 / PMID 42302964 · Allogeneic Transplantation in rare MDS/MPN with Neutrophilia: Age and Disease Burden Determine Outcome (n=85, 8 German centers, 30 years — largest cohort) · 9/10 · Defines prognostic factors (age, blasts, EZH2/TET2) for the only curative therapy in this ultra-rare entity. 🟡 UNDERSERVED_POPULATION
AI/ML in Clinical Diagnostics and Imaging
- TR-2026-06-17-002 / PMID 42304076 · Multi-omic analysis of deep learning-derived phenotypes links ophthalmic imaging to cardiovascular and neurological traits (UK Biobank, Nat Cardiovasc Res) · 9/10 · Retinal adversarial autoencoder embeddings (OCT + fundus) predict ischemic heart disease, cerebrovascular disease, Parkinson's, dementia — identifies lipid metabolism and neurodegeneration gene sets as mediating pathways. 🟢 NEAR_TERM_IMPLEMENTABLE
Early Cancer Detection (Liquid Biopsy, ctDNA, cfDNA)
- TR-2026-06-17-005 / PMID 42303501 · Pleural Fluid Outperforms Plasma for Detection of Clinically Relevant Mutations in Lung Cancer-Associated Malignant Pleural Effusion (n=70, prospective, NSCLC) · 8/10 · PF cfDNA detected mutations in 57% vs 41% plasma; only 26% concordance between compartments — supports routine PF cfDNA NGS in NSCLC with effusion to expand targeted therapy access. 🔴 EARLY_CANCER_DETECTION
- TR-2026-06-17-008 / PMID 42303449 · MAPLE: ultrasensitive cfDNA methylation haplotype enrichment for CRC early detection (Genome Research, 95% spec, 80% sens at stage I-II) · 7/10 → HIGH (flag) · Novel enrichment technology using short capture probes achieves 28x better read efficiency than conventional methods; LightGBM classifier works with 0.05% of standard sequencing depth. 🔴 EARLY_CANCER_DETECTION
Cardiovascular-Metabolic (GLP-1, SGLT2)
- TR-2026-06-17-007 / PMID 42304171 · Comparative Effects of Antidiabetic Drugs on Body Composition: NMA of 41 RCTs (n=2,906, Diabetes Obes Metab) · 8/10 · Tirzepatide delivers greatest fat mass reduction (MD -10.70 kg vs placebo) but also significant lean mass loss (MD -4.40 kg); SGLT2i modest fat loss with minimal lean impact — directly guides patient counseling and drug selection. 🟢 NEAR_TERM_IMPLEMENTABLE
- ⚠️ T7 zero-HIGH streak broken (was 6 days). Refined query with outcomes/trial filters effective.
Aging, Longevity, and Population Health
- TR-2026-06-17-006 / PMID 42302219 · Cognitive Aging and Brain Health: Super Movers vs Non-Super Movers (Neurology, n=~4,900, multi-cohort pooled) · 8/10 · Octogenarians with gait speed ≥1.5 SD above mean have 51% lower risk of incident cognitive impairment (HR 0.49, 95% CI 0.28-0.71), slower decline, and preserved hippocampal volume — absent postmortem pathology differences suggests reserve mechanisms. 🟢 NEAR_TERM_IMPLEMENTABLE
- ⚠️ T8 zero-HIGH streak broken (was 7 days). humans[MeSH] filter successfully reducing non-human noise.
🟢⚪ STANDARD (5-7) — Top by Topic
Hematologic Malignancies
- TR-2026-06-17-009 / PMID 42303614 · Metabolic heterogeneity and niche rewiring in plasma cells from MGUS/SBP/MM (Blood Cancer J, Mayo/Helmholtz MSI) · 7/10 · Spatial metabolomics
- TR-2026-06-17-010 / PMID 42303828 · XPO1 inhibition (KPT-330) radiosensitizes ENKTL via c-Myc-RAD51/CHEK1 axis (Br J Cancer) · 6/10 · Mechanistic + 2 clinical cases
- TR-2026-06-17-017 / PMID 42302252 · Shared decision-making gaps in CLL (Israeli national survey, Leuk Lymphoma) · 5/10 · Patient-centered
Early Cancer Detection / Liquid Biopsy
- TR-2026-06-17-011 / PMID 42299848 · Longitudinal cfDNA aneuploidy predicts pembrolizumab non-response in metastatic urothelial cancer (Mol Oncol) · 7/10
- TR-2026-06-17-014 / PMID 42298760 · Pancreatic cancer early detection biomarkers for high-risk individuals: PRECEDE Consortium review (Int J Cancer) · 6/10
- TR-2026-06-17-015 / PMID 42299856 · Methylated CpG sites liquid biopsy for ovarian cancer (Mol Oncol) · 6/10
AI/ML in Diagnostics
- TR-2026-06-17-016 / PMID 42304009 · Uncertainty-aware ViT-BiLSTM Bayesian framework for chest X-ray diagnostics (Sci Rep, AUC 0.986) · 6/10
- TR-2026-06-17-020 / PMID 42304059 · AI-based DUX4 repressor identification in FSHD (Sci Rep, in vitro) · 5/10
Precision Oncology
- TR-2026-06-17-022 / PMID 42303056 · KRAS G12D inhibitor resistance reversal by nimotuzumab (MEK/ERK/UPR, Cancer Lett) · 5/10
Cardiovascular-Metabolic
- TR-2026-06-17-018 / PMID 42302513 · Self-selected time-restricted eating shows equivalent 12-month weight maintenance vs early/late TRE (Clin Nutr, RCT follow-up) · 6/10
Aging / Longevity
- TR-2026-06-17-012 / PMID 42301777 · Diminished RNAPII transcriptional activity and splice changes drive gene length-biased aging transcriptome rewiring (PNAS, Northwestern/Shilatifard) · 7/10 · Basic science, anti-aging target identification
Rare Diseases
- TR-2026-06-17-019 / PMID 42299455 · Microperimetry validates visual function changes post-voretigene gene therapy in RPE65 retinal dystrophy (Ophthalmic Genet) · 6/10
- TR-2026-06-17-021 / PMID 42299015 · ALS: Therapeutic innovations and evolving regulatory approaches (review, CNS Neurol Disord Drug Targets) · 5/10
💡 UNSOLICITED FINDS
- TR-2026-06-17-SEN-001 / PMID 42302434 · Blood cancers in Indigenous populations: global systematic review 1954-2024 (126 articles, 16 countries, Cancer Epidemiol) · 6/10 · Indigenous peoples globally have consistently poorer blood cancer survival; 90% of evidence concentrated in 4 high-income nations — major health equity signal. 🟡 UNDERSERVED_POPULATION
- TR-2026-06-17-SEN-002 / PMID 42302999 · CAPA incidence/mortality umbrella review (Respir Med; 11.3% ICU incidence, 51.6% mortality, OR 3.08 vs non-CAPA) · 6/10 · Useful surveillance signal for immunosuppressed/critically ill patients
📊 TODAY'S BREAKDOWN
By research category:
- Diagnostics: 8
- Treatment Innovation: 7
- Early Detection: 4
- Prevention: 3
- Drug Development: 3
- Genomics/Precision Medicine: 2
- Public Health: 3
By evidence maturity:
- Validated: 10
- Exploratory: 13
By source type:
- Peer-reviewed: 23 | Preprint: 0
By watchlist topic (reviewed / kept / highest score):
| Topic | Raw | Reviewed | Kept | Highest |
|---|---|---|---|---|
| T1 Hematologic | 51 | 20 | 6 | 9 |
| T2 CBC/ML | 0 | 0 | 0 | 0 |
| T3 Liquid biopsy | 20 | 20 | 6 | 9 |
| T4 AI/ML | 64 | 20 | 4 | 9 |
| T5 Precision oncology | 73 | 20 | 2 (unique) | 9 |
| T6 Novel therapeutics | 85 | 20 | 2 (unique) | 9 |
| T7 Cardio-metabolic | 60 | 20 | 2 | 8 |
| T8 Aging/longevity | 28 | 20 | 2 | 8 |
| T9 Rare diseases | 22 | 20 | 3 | 9 |
| Sentinel | 1154 | 10 | 2 | 6 |
Topics with zero 8+ articles this run: None (all zero-HIGH streaks broken today) ✅
🔧 RUN NOTES
T2 (CBC/ML) zero-signal: Query refined per 2026-06-16 notes (omit 'peripheral blood', add 'blood smear morphology', 'hematology analyzer', 'leukocyte differential'). Still returned 0 results. This is now a 2-day zero-signal streak with the refined query. Recommendation: consider broader AI+hematology search without strict CBC specificity, or check preprint servers (bioRxiv/medRxiv).
T7 zero-HIGH streak broken (day 6): Refined query with outcomes/randomized filter successfully reduced aesthetic surgery noise. Strong GLP-1/tirzepatide body composition NMA found.
T8 zero-HIGH streak broken (day 7): humans[MeSH] filter confirmed effective. Two HIGH articles identified: Neurology (cognitive aging) and PNAS (aging transcriptomics). Both continue to validate filter approach.
High de-duplication day: PMID 42303978 matched T1, T3, T5, T6 simultaneously — maintained as single record. Similar overlaps for 42302353 (T1+T6) and 42302964 (T1+T9). Total unique high-signal articles = 8 (after dedup).
Alert cap applied: 5 article alerts sent (cap per pipeline rules). Three additional HIGH articles (TR-006 Super Movers/Neurology, TR-007 GLP-1 NMA, TR-008 MAPLE cfDNA) are included in Output A but not alerted.
Query refinement progress:
- T7 refined query: ✅ effective (outcomes/trial filter reduced noise)
- T8 humans[MeSH]: ✅ effective (28 results vs 56 raw before filter)
- T2 refined query: ❌ still zero — further action needed
Action items for next run:
- T2: Consider adding bioRxiv/medRxiv preprint scan OR broader "hematology + AI" query
- PMID 42303978 (MEN1 cfDNA): Monitor for full abstract becoming available — classified from metadata only
- T5/T6 overlap: Consider query deduplication at search level to reduce redundant review burden